IMVT

NASD Immunovant Inc
Oct 9, 2026 · 1:21 AM ET EOD Market Closed

$30.26 ↑ +0.00 (+0.00%) Trading Up from the previous close of $30.26, $1.24 below the day’s high of $31.50

YTD change
+19.04%
vs 20-day SMA
-13.85%
vs 200-day SMA
-4.93%

Price ranges

Previous day
$31.58 $32.75
open $31.72 close $32.04
+$0.32 (+1.01%)
Today
$29.80 $31.50
open $31.40 now $30.26
-$1.14 (-3.63%)
Past week
$31.36 $34.60
from $33.78 now $30.26
-$3.52 (-10.42%)
Past month
$31.36 $38.93
from $38.75 now $30.26
-$8.49 (-21.91%)
This year
$22.79 $45.42
from $25.42 now $30.26
+$4.84 (+19.04%)

Price & Performance

+5.53 (+22.36%) / 6M

$22.86$30.77$38.69$46.60Apr 8Jul 9Oct 8

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 43.7% away from all-time highs of $53.75
  • IMVT is up 19% since the beginning of the year
  • IMVT is up 88% over the past 12 months
  • IMVT is down 22% over the past 1 month
  • 20% of all IMVT investors are betting against IMVT

IMVT reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +88.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.75
Earnings momentum -1.8% Quarterly EPS growth
Quarterly change -1.8%

Valuation

P/E ratio N/A
Enterprise value $5.8B
Beta 1.50

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$797.8M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $6.3B

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It develops a novel, fully human monoclonal antibody, IMVT-1401, which selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded on July 6, 2018 and is headquartered in Durham, NC.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $407.44 -1.37%
MRNA Moderna, Inc. $197.00 +0.26%
RVMD Revolution Medicines, Inc. $188.12 -6.35%
ROIV Roivant Sciences Ltd. $34.21 -1.55%
BNTX BioNTech SE Sponsored ADR $92.06 -3.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.